| 2026-05-15 |
P990081-S058 |
PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody |
Normal 180 Day Track |
MVC |
— |
— |
| 2026-05-15 |
P190031-S015 |
HER2 Dual ISH DNA Probe Cocktail |
Normal 180 Day Track |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2026-01-06 |
P200019-S013 |
VENTANA anti-MSH6 (SP93) Antibody |
30-Day Notice |
QNH |
— |
— |
| 2025-12-15 |
P990081-S059 |
PATHWAY anti- HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody |
Normal 180 Day Track |
MVC |
— |
— |
| 2025-12-15 |
P190031-S014 |
HER2 Dual ISH DNA Probe Cocktail |
Normal 180 Day Track |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2025-09-04 |
P190024-S015 |
CINtec PLUS Cytology |
30-Day Notice |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2025-07-31 |
P190024-S014 |
CINtec PLUS Cytology |
Real-Time Process |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2025-06-20 |
P990081-S057 |
PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody |
30-Day Notice |
MVC |
— |
— |
| 2025-06-20 |
P230018-S001 |
VENTANA CLDN18 (43-14A) RxDx Assay |
30-Day Notice |
QZJ |
Immunohistochemistry Assay, Antibody, Claudin 18 |
Hematology |
| 2025-06-20 |
P220006-S007 |
VENTANA FOLR1 (FOLR-2.1) RxDx Assay |
30-Day Notice |
QUL |
Immunohistochemistry Assay, Antibody, Folr1 |
Hematology |
| 2025-06-20 |
P200019-S012 |
VENTANA MMR RxDx Panel |
30-Day Notice |
QNH |
— |
— |
| 2025-06-20 |
P160046-S020 |
VENTANA PD-L1 (SP263) ASSAY |
30-Day Notice |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2025-06-20 |
P140025-S025 |
VENTANA ALK (D5F3) CDX ASSAY |
30-Day Notice |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2025-06-20 |
P020055-S032 |
PATHWAY® Anti-c-KIT (9.7) Primary Antibody |
30-Day Notice |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2025-06-16 |
P190031-S013 |
VENTANA HER2 DualL ISH DNA Probe Cocktail |
30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2025-06-11 |
P990081-S056 |
PATHWAY Anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody |
Normal 180 Day Track |
MVC |
— |
— |
| 2025-05-16 |
P190031-S012 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
Normal 180 Day Track |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2025-04-25 |
P190024-S013 |
CINtec PLUS Cytology |
Normal 180 Day Track |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2025-04-17 |
P200019-S011 |
VENTANA MMR RxDx Panel |
30-Day Notice |
QNH |
— |
— |
| 2025-03-12 |
P140025-S024 |
VENTANA ALK (D5F3) CDx Assay |
Normal 180 Day Track |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2025-01-27 |
P990081-S055 |
PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody |
Panel Track |
MVC |
— |
— |
| 2025-01-08 |
P220006-S006 |
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay |
Real-Time Process |
QUL |
Immunohistochemistry Assay, Antibody, Folr1 |
Hematology |
| 2024-12-20 |
P200019-S010 |
VENTANA MMR RxDx Panel |
Normal 180 Day Track |
QNH |
— |
— |
| 2024-11-20 |
P990081-S054 |
PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody |
Panel Track |
MVC |
— |
— |
| 2024-10-23 |
P160046-S019 |
VENTANA PD-L1 (SP263) CDx Assay |
Normal 180 Day Track |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2024-10-18 |
P230018 |
VENTANA CLDN18 (43-14A) RxDx Assay |
Original |
QZJ |
Immunohistochemistry Assay, Antibody, Claudin 18 |
Hematology |
| 2024-04-01 |
P160002-S024 |
VENTANA PD-L1(SP142) Assay |
30-Day Notice |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2024-01-26 |
P990081-S053 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
Real-Time Process |
MVC |
— |
— |
| 2024-01-26 |
P220006-S005 |
VENTANA FOLR1 (FOLR-2.1) RxDx Assay |
Real-Time Process |
QUL |
Immunohistochemistry Assay, Antibody, Folr1 |
Hematology |
| 2024-01-26 |
P200019-S009 |
VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status) |
Real-Time Process |
QNH |
— |
— |
| 2024-01-26 |
P190031-S010 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
Real-Time Process |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2024-01-26 |
P190024-S012 |
CINtec PLUS Cytology |
Real-Time Process |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2024-01-26 |
P160046-S018 |
VENTANA PD-Ll (SP263) Assay |
Real-Time Process |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2024-01-26 |
P160002-S023 |
VENTANA PD-Ll (SP142) Assay |
Real-Time Process |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2024-01-26 |
P140025-S023 |
VENTANA ALK (D5F3) CDx Assay |
Real-Time Process |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2024-01-26 |
P100027-S041 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
Real-Time Process |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2024-01-26 |
P020055-S031 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
Real-Time Process |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2023-11-08 |
P990081-S052 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
30-Day Notice |
MVC |
— |
— |
| 2023-11-08 |
P220006-S004 |
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay |
30-Day Notice |
QUL |
Immunohistochemistry Assay, Antibody, Folr1 |
Hematology |
| 2023-11-08 |
P200019-S008 |
VENTANA MMR RxDx Panel, VENTANA ANTI-MLH1 (M1), VENTANA ANTI-MSH6 (SP93), VENTANA ANTI-MSH2 (G219-1129), VENTANA ANTI-PM |
30-Day Notice |
QNH |
— |
— |
| 2023-11-08 |
P190031-S009 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2023-11-08 |
P190024-S011 |
CINtec PLUS Cytology |
30-Day Notice |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2023-11-08 |
P160046-S017 |
VENTANA PD-Ll (SP263) Assay |
30-Day Notice |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2023-11-08 |
P160002-S022 |
VENTANA PD-Ll (SP142) Assay |
30-Day Notice |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2023-11-08 |
P140025-S022 |
VENTANA ALK (D5F3) CDx Assay |
30-Day Notice |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2023-11-08 |
P100027-S040 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2023-11-08 |
P020055-S030 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
30-Day Notice |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2023-08-29 |
P990081-S051 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
30-Day Notice |
MVC |
— |
— |
| 2023-08-29 |
P220006-S002 |
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay |
30-Day Notice |
QUL |
Immunohistochemistry Assay, Antibody, Folr1 |
Hematology |
| 2023-08-29 |
P200019-S007 |
VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status) |
30-Day Notice |
QNH |
— |
— |
| 2023-08-29 |
P190031-S008 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2023-08-29 |
P190024-S010 |
CINtec PLUS Cytology |
30-Day Notice |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2023-08-29 |
P160046-S016 |
VENTANA PD-Ll (SP263) Assay |
30-Day Notice |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2023-08-29 |
P160002-S021 |
VENTANA PD-Ll (SP142) Assay |
30-Day Notice |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2023-08-29 |
P140025-S021 |
VENTANA ALK (D5F3) CDx Assay |
30-Day Notice |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2023-08-29 |
P100027-S039 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2023-08-29 |
P020055-S029 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
30-Day Notice |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2023-08-23 |
P220006-S001 |
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay |
Normal 180 Day Track |
QUL |
Immunohistochemistry Assay, Antibody, Folr1 |
Hematology |
| 2023-03-01 |
P160046-S013 |
VENTANA PD-L1 (SP263) Assay |
Panel Track |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2023-02-07 |
P160002-S020 |
VENTANA PD-L1 (SP142) Assay |
Special (Immediate Track) |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2023-01-30 |
P190024-S009 |
CINtec PLUS Cytology |
30-Day Notice |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2022-11-14 |
P220006 |
VENTANA FOLR1 (FOLR-2.1) RxDx Assay |
Original |
QUL |
Immunohistochemistry Assay, Antibody, Folr1 |
Hematology |
| 2022-11-10 |
P990081-S050 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
30-Day Notice |
— |
— |
— |
| 2022-11-10 |
P200019-S006 |
VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status) |
30-Day Notice |
QNH |
— |
— |
| 2022-11-10 |
P190031-S007 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
30-Day Notice |
— |
— |
— |
| 2022-11-10 |
P190024-S008 |
CINtec PLUS Cytology |
30-Day Notice |
— |
— |
— |
| 2022-11-10 |
P160046-S015 |
VENTANA PD-L1 (SP263) Assay |
30-Day Notice |
— |
— |
— |
| 2022-11-10 |
P160002-S019 |
VENTANA PD-L1 (SP142) Assay |
30-Day Notice |
— |
— |
— |
| 2022-11-10 |
P140025-S020 |
VENTANA ALK (D5F3) CDx Assay |
30-Day Notice |
— |
— |
— |
| 2022-11-10 |
P100027-S038 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
30-Day Notice |
— |
— |
— |
| 2022-11-10 |
P020055-S028 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
30-Day Notice |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2022-09-30 |
P990081-S047 |
PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody |
Panel Track |
MVC |
— |
— |
| 2022-07-29 |
P990081-S048 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
30-Day Notice |
— |
— |
— |
| 2022-07-29 |
P200019-S005 |
VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status) |
30-Day Notice |
QNH |
— |
— |
| 2022-07-29 |
P190031-S005 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2022-07-29 |
P190024-S007 |
CINtec PLUS Cytology |
30-Day Notice |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2022-07-29 |
P160046-S014 |
VENTANA PD-L1 (SP263) Assay |
30-Day Notice |
— |
— |
— |
| 2022-07-29 |
P160002-S018 |
VENTANA PD-L1 (SP142) Assay |
30-Day Notice |
— |
— |
— |
| 2022-07-29 |
P140025-S018 |
VENTANA ALK (D5F3) CDx Assay |
30-Day Notice |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2022-07-29 |
P100027-S037 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2022-07-29 |
P020055-S027 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
30-Day Notice |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2022-07-21 |
P990081-S046 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
Special (Immediate Track) |
MVC |
— |
— |
| 2022-07-21 |
P200019-S004 |
VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status) |
Special (Immediate Track) |
QNH |
— |
— |
| 2022-07-21 |
P190031-S004 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
Special (Immediate Track) |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2022-07-21 |
P190024-S006 |
CINtec PLUS Cytology |
Special (Immediate Track) |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2022-07-21 |
P160046-S012 |
VENTANA PD-Ll (SP263) Assay |
Special (Immediate Track) |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2022-07-21 |
P160002-S017 |
VENTANA PD-Ll (SP142) Assay |
Special (Immediate Track) |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2022-07-21 |
P140025-S017 |
VENTANA ALK (D5F3) CDx Assay |
Special (Immediate Track) |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2022-07-21 |
P100027-S036 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
Special (Immediate Track) |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2022-07-21 |
P020055-S026 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
Special (Immediate Track) |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2022-06-10 |
P990081-S045 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
135 Review Track For 30-Day Notice |
MVC |
— |
— |
| 2022-06-10 |
P200019-S003 |
VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status) |
135 Review Track For 30-Day Notice |
QNH |
— |
— |
| 2022-06-10 |
P190031-S003 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
135 Review Track For 30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2022-06-10 |
P190024-S005 |
CINtec PLUS Cytology |
135 Review Track For 30-Day Notice |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2022-06-10 |
P160046-S011 |
VENTANA PD-L1 (SP263) Assay |
135 Review Track For 30-Day Notice |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2022-06-10 |
P160002-S016 |
VENTANA PD-L1(SP142) Assay |
135 Review Track For 30-Day Notice |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2022-06-10 |
P140025-S016 |
VENTANA ALK (D5F3) CDx Assay |
135 Review Track For 30-Day Notice |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2022-06-10 |
P100027-S035 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
135 Review Track For 30-Day Notice |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2022-06-10 |
P020055-S025 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
135 Review Track For 30-Day Notice |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2021-10-15 |
P160046-S010 |
VENTANA PD-L1 (SP263) Assay |
Panel Track |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2021-09-28 |
P160002-S015 |
VENTANA PD-L1 (SP142) Assay |
Special (Immediate Track) |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2021-05-20 |
P990081-S044 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
Real-Time Process |
MVC |
— |
— |
| 2021-05-20 |
P190031-S002 |
VENTANA HER2 Dual ISI-I DNA Probe Cocktail |
Real-Time Process |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2021-05-20 |
P190024-S003 |
CINtec PLUS Cytology |
Real-Time Process |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2021-05-20 |
P160046-S009 |
VENTANA PD-LI (SP263) Assay |
Real-Time Process |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2021-05-20 |
P160002-S014 |
VENTANA PD-LI (SP142) Assay |
Real-Time Process |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2021-05-20 |
P140025-S015 |
VENTANA ALK (D5F3) CDx Assay |
Real-Time Process |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2021-05-20 |
P100027-S034 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
Real-Time Process |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2021-05-20 |
P020055-S024 |
PATI-IWAY Anti-c-KIT (9.7) Primary Antibody |
Real-Time Process |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2021-04-22 |
P200019 |
VENTANA MMR RxDx Panel |
Original |
QNH |
— |
— |
| 2021-03-29 |
P190024-S004 |
CINtec PLUS Cytology |
30-Day Notice |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2021-03-03 |
P140025-S014 |
VENTANA ALK (D5F3) CDx Assay |
Normal 180 Day Track |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2020-11-13 |
P990081-S043 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
Real-Time Process |
MVC |
— |
— |
| 2020-11-13 |
P190031-S001 |
VENTANA HER2 Dual ISH DNA Probe Cocktail |
Real-Time Process |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2020-11-13 |
P190024-S002 |
CINtec PLUS Cytology |
Real-Time Process |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2020-11-13 |
P160046-S008 |
VENTANA PD-L1 (SP263) Assay |
Real-Time Process |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2020-11-13 |
P160002-S013 |
VENTANA PD-L1 (SP142) Assay |
Real-Time Process |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2020-11-13 |
P140025-S013 |
VENTANA ALK (D5F3) CDx Assay |
Real-Time Process |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2020-11-13 |
P100027-S033 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
Real-Time Process |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2020-11-13 |
P020055-S023 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
Real-Time Process |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2020-08-14 |
P190024-S001 |
CINtec PLUS Cytology |
Normal 180 Day Track |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |
| 2020-07-28 |
P190031 |
HER2 Dual ISH DNA Probe Cocktail |
Original |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2020-05-18 |
P160002-S012 |
Ventana PD-L1 (SP142) Assay |
Normal 180 Day Track |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2020-03-31 |
P990081-S042 |
PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody |
Real-Time Process |
MVC |
— |
— |
| 2020-03-31 |
P160046-S007 |
VENTANA PD-L1 (SP263) Assay |
Real-Time Process |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2020-03-31 |
P160002-S011 |
VENTANA PD-L1(SP142) Assay |
Real-Time Process |
PLS |
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 |
Unknown |
| 2020-03-31 |
P140025-S012 |
VENTANA ALK (D5F3) CDx Assay |
Real-Time Process |
PKW |
Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Unknown |
| 2020-03-31 |
P100027-S032 |
INFORM HER2 Dual ISH DNA Probe Cocktail |
Real-Time Process |
NYQ |
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer |
Unknown |
| 2020-03-31 |
P020055-S022 |
PATHWAY Anti-c-KIT (9.7) Primary Antibody |
Real-Time Process |
NKF |
Immunohistochemistry Antibody Assay, C-Kit |
Hematology |
| 2020-03-10 |
P190024 |
CINtec PLUS Cytology |
Original |
QKF |
Immunocytochemistry Assay, P16/Ki-67 |
Hematology |